XTalks

APRIL 15, 2025

XTALKS WEBINAR: Leveraging AI in Clinical Development to Innovate with Greater Confidence Live and On-Demand: Tuesday, June 3, 2025 , at 10am EDT (4pm CEST / EU-Central) Register for this free webinar to learn how AI-powered technology can uncover potential study design risks by identifying areas of patient burden and complexity.

FDA Approval 66

FDA Approval Bacteria DNA Bacterium 66

XTalks

NOVEMBER 6, 2020

The Burnaby, BC-based company developed the oral DNA-based vaccine using its proprietary bacTRL Gene Therapy Platform, which uses genetically modified bifidobacteria as carriers of genetic vaccine elements on a DNA plasmid. Related: Red Meat Allergy Test Gets FDA Clearance. “We

Clinical Trials 75

Clinical Trials Clinical Trials Vaccination Vaccine 75

XTalks

AUGUST 2, 2023

With Blackstone Life Sciences, up to €300 million (around $315 million USD) will be invested to accelerate pivotal studies and clinical development programs for formulating the subcutaneous delivery of the anti-CD38 antibody Sarclisa (isatuximab) for the treatment of multiple myeloma. Global sales of Prograf totalled 198.8

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

DECEMBER 24, 2020

Omer maintains that the solution to this challenge is something that’s already in practice by developers of the mRNA vaccines. What you do is you insist that a proper clinical development program is followed and that has been followed with trial data of tens of thousands of people,” says Dr. Omer.

Life Science 111

Life Science Vaccination Vaccine Gene 111